DTL
XENE icon

Dynamic Technology Lab’s Xenon Pharmaceuticals XENE Stock Holding History

Dynamic Technology Lab’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-9,371
Closed -$320K – 1445
2023
Q3 		$320K Buy
+9,371
New +$351K 0.03% 633
2022
Q4 		– Sell
-9,990
Closed -$361K – 1584
2022
Q3 		$361K Buy
+9,990
New +$359K 0.04% 742
2022
Q2 		– Sell
-13,993
Closed -$428K – 1589
2022
Q1 		$428K Buy
+13,993
New +$419K 0.05% 647
2020
Q2 		– Sell
-13,539
Closed -$154K – 1402
2020
Q1 		$154K Buy
+13,539
New +$193K 0.03% 831
2017
Q3 		– Sell
-13,001
Closed -$41K – 1414
2017
Q2 		$41K Buy
+13,001
New +$50.8K 0.01% 962

Other funds holding XENE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dynamic Technology Lab's XENE Position: Q4 2023 in Review

Dynamic Technology Lab sold out of Xenon Pharmaceuticals (XENE) in Q4 2023, closing a stake of 9,371 shares — an estimated $320K sold.

Dynamic Technology Lab first reported a position in XENE in Q2 2017 and held it in 5 quarters. The position peaked at $428K in Q1 2022. 204 funds tracked by Wall St. Rank hold XENE as of Q4 2023.

  • Dynamic Technology Lab reported no remaining Xenon Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Dynamic Technology Lab sold 9,371 Xenon Pharmaceuticals shares in Q4 2023, an estimated $320K.
  • Dynamic Technology Lab first reported a position in Xenon Pharmaceuticals in Q2 2017 and held it in 5 quarters.
  • Dynamic Technology Lab's Xenon Pharmaceuticals position peaked at $428K in Q1 2022.
  • 204 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q4 2023.

Based on Dynamic Technology Lab's 13F filing for Q4 2023, filed 9 Feb 2024.